Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Relapse in Prescription Opioid Abuse Among Pain Patients
NCT01967641Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Nov 2005
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Nov 2005; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01967641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967641.